Skip to main content
. 2020 Jun 1;20:834. doi: 10.1186/s12889-020-08586-9

Table 3.

Cox Regression Analysis of Association between Clinical Risk Factors and Incidence of Hypertension

Covariate Univariate model
HR (95% CI)
P value Multivariable model
HR (95% CI)
P value
Male 1.14 (0.80, 1.62) 0.47
Age (per year increase) 1.04 (1.03, 1.05) < 0.001 1.02 (1.00, 1.03) 0.06
BMI (per kg/m2increase) 1.09 (1.04, 1.14) < 0.001 1.07 (1.01, 1.13) 0.02
Han ethnicity 1.27 (0.80, 2.02) 0.32
Current smoking 0.84 (0.59, 1.21) 0.35
Current alcohol use 0.83 (0.58, 1.18) 0.30
eGFR (per ml/min increase) 0.99 (0.98, 1.00) < 0.01 NA NA
Diabetes 1.19 (0.61, 2.32) 0.62
TC > 5.2 (mmol/l) 1.24 (0.79, 1.96) 0.36
TG > 1.7 (mmol/l) 1.18 (0.86, 1.63) 0.31
HDL-c < 1.0 (mmol/l) 1.22 (0.90, 1.67) 0.20
LDL-c > 4.1(mmol/l) 1.42 (0.45, 4.45) 0.55
Dyslipidemia 1.28 (0.95, 1.73) 0.11
HBs Ag+ 1.16 (0.74, 1.82) 0.51
HCV-Ab+ 1.69 (1.05, 2.72) 0.03 NA NA
Route of HIV transmission NA NA
 Heterosexual 0.99 (0.55, 1.80) 0.98
 MSM 1.21 (0.67, 2.17) 0.53
 Blood transfusion 4.12 (2.08, 8.19) < 0.001
 Others Reference

Years since HIV diagnosis

(per year increase)

1.06 (0.97, 1.14) 0.19

Baseline CD4+ cell count

(per cells/mm3increase)

0.999 (0.997, 1.000) 0.03 1.003 (1.001, 1.004) < 0.01

Baseline HIV Viral load

(per log10 copies/ml increase)

0.97 (0.74, 1.27) 0.82
Stavudine exposure 1.92 (1.42, 2.60) < 0.001 NA NA
Zidovudine exposure 0.50 (0.36, 0.71) < 0.001 0.15 (0.10, 0.24) < 0.001
TDF exposure 0.46 (0.33, 0.64) < 0.001 0.13 (0.08, 0.21) < 0.001

Recent CD4+ cell count

(per cells/mm3increase)

0.996 (0.995, 0.997) < 0.001
Recent CD4+/CD8+ ratio 0.09 (0.05, 0.17) < 0.001 0.14 (0.06, 0.31) < 0.001

Recent VL

(per log10 copies/ml increase)

1.87 (1.65, 2.12) < 0.001 1.28 (1.08, 1.51) < 0.01

Abbreviations: HR Hazard ratio; CI confidence interval; NA not available; BMI body mass index; TC total cholesterol; TG triglycerides; HDL-c high-density lipoprotein cholesterol; LDL-c low-density lipoprotein cholesterol; HBsAg+ hepatitis B surface antigen; HCV Ab hepatitis C antibody; HIV human immunodeficiency virus; MSM men who have sex with men; TDF tenofovir disoproxil fumarate; VL HIV-1 viral load